Chester County News and Community Website
WILMINGTON, DE — In a major advance for breast cancer treatment, AstraZeneca and Daiichi Sankyo announced that their drug DATROWAY (datopotamab deruxtecan-dlnk) extended the lives of patients with metastatic triple-negative …
Breakthrough Drug Shows Unprecedented Survival Gains in Aggressive Breast Cancer Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported breakthrough results from the Phase III DESTINY-Breast05 trial, showing that their drug ENHERTU (fam-trastuzumab deruxtecan-nxki) cut the risk of disease recurrence or …
AstraZeneca’s Enhertu Slashes Breast Cancer Recurrence Risk in Landmark Trial Read More
WILMINGTON, DE — Amalgam Rx, Inc. announced the publication of two peer-reviewed research papers validating its Medical-Grade AI™ framework, a clinically governed system that delivers safe and highly engaging digital …
Amalgam Rx’s Medical-Grade AI Redefines Safety and Engagement in Healthcare Read More
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) announced it has renewed a multi-year, worldwide, non-exclusive, royalty-bearing patent license agreement with Seiko Solutions Inc., extending its long-standing relationship with the Japanese …
InterDigital Renews Global Patent License with Seiko Solutions Covering 3G, 4G, and 5G Technologies Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) announced it will release its fourth-quarter fiscal 2025 financial results at approximately 5 p.m. ET on Tuesday, November 4, 2025. The company will …
Ashland to Report Fourth-Quarter Fiscal 2025 Results on November 4 Read More
PORTO, Portugal & WILMINGTON, DE — Naoris Protocol has announced the launch of Naoris Ventures, a new venture arm designed to accelerate the adoption of decentralized, post-quantum security infrastructure across …
Naoris Protocol Launches Venture Arm to Advance Post-Quantum Security Adoption Read More WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) announced two key licensing agreements that extend the reach of its intellectual property portfolio — a renewed patent license with Sharp and a …
InterDigital Expands Licensing Portfolio With Sharp Renewal and New EV Charging Deal Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their antibody-drug conjugate ENHERTU® (fam-trastuzumab deruxtecan-nxki), when used before surgery and followed by standard therapy, achieved a pathologic complete response in …
ENHERTU Combination Shows Promising Results in Early Breast Cancer Trial Read More WILMINGTON, DE — Levitask has announced the development of its patent-pending T-Mech mechanism, an ergonomic innovation designed to bridge the gap between sitting and standing. The system introduces a new …
Levitask Unveils Patent-Pending T-Mech Mechanism, Introducing New Era of Elevated Seating Read More WILMINGTON, DE — AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and …
AstraZeneca and Amgen Secure FDA Approval for TEZSPIRE to Treat Chronic Rhinosinusitis with Nasal Polyps Read More